Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
Not Confirmed
Not Confirmed
30 September-02 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Industry Trade Show
Not Confirmed
30 September-02 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
23 Apr 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/flare-therapeutics-appoints-douglas-manion-md-frcp-c-as-chief-executive-officer-302124574.html
10 Apr 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/flare-therapeutics-presents-data-at-aacr-2024-annual-meeting-characterizing-pparg-derived-immune-cell-patterns-in-urothelial-cancer-patients-after-anti-pd1-therapy-302112197.html
26 Jan 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/flare-therapeutics-presents-fx-909-phase-1-dose-escalation-and-expansion-clinical-trial-design-at-the-2024-asco-genitourinary-cancers-symposium-302045411.html
03 Nov 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/flare-therapeutics-presents-new-translational-data-in-support-of-lead-asset-fx-909-for-the-treatment-of-muscle-invasive-urothelial-cancer-at-sitc-2023-annual-meeting-301976751.html
31 Oct 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/flare-therapeutics-to-present-new-translational-data-in-support-of-clinical-candidate-fx-909s-phase-1-development-at-sitc-2023-annual-meeting-301972210.html
19 Oct 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/flare-therapeutics-announces-first-patients-dosed-in-first-in-human-phase-1-clinical-study-of-fx-909-in-advanced-solid-malignancies-including-urothelial-cancer-301961490.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?